Resistance to anti-peptide deformylase drugs

Author： Giglione Carmela Meinnel Thierry

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.5, Iss.3, 2001-06, pp. : 415-418

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peptide deformylase: a target for novel antibiotics?

By Pei D.

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 1, 2001-02 ,pp. : 23-40

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of peptide deformylase inhibitors

By Chen D Yuan Z

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 9, 2005-09 ,pp. : 1107-1116

Informa Healthcare

Access to resources Recommend Favorite

Peptide deformylase as an emerging target for antiparasitic agents

By Giglione C. Meinnel T.

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 1, 2001-02 ,pp. : 41-57

Informa Healthcare

Access to resources Recommend Favorite

Peptide deformylase inhibitors: a survey of the patent literature

By Molteni Valentina Kreusch Andreas

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 10, 2005-10 ,pp. : 1423-1437

Informa Healthcare

Access to resources Recommend Favorite

Overview of Anti-Tuberculosis (TB) Drugs and Their Resistance Mechanisms

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 11, 2007-11 ,pp. : 1177-1185

Bentham Science Publishers

Access to resources Recommend Favorite